Kang Zhang Selected Research

Carbonic Anhydrase IV

8/2007	Identification and characterization of a novel mutation in the carbonic anhydrase IV gene that causes retinitis pigmentosa.
1/2005	Mutant carbonic anhydrase 4 impairs pH regulation and causes retinal photoreceptor degeneration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kang Zhang Research Topics

Disease

40	Macular Degeneration (Age-Related Maculopathy) 01/2022 - 04/2002
26	Neoplasms (Cancer) 01/2022 - 06/2011
14	Infections 01/2021 - 05/2014
11	Glaucoma 01/2022 - 01/2011
11	Choroidal Neovascularization 01/2016 - 01/2006
7	Inflammation (Inflammations) 06/2022 - 08/2012
7	Cataract (Cataracts) 01/2021 - 04/2006
7	Open-Angle Glaucoma (Glaucoma, Open Angle) 09/2016 - 02/2008
6	Atrophy 06/2018 - 04/2002
6	Retinitis Pigmentosa (Pigmentary Retinopathy) 06/2018 - 01/2006
5	COVID-19 12/2021 - 01/2020
5	Blindness (Hysterical Blindness) 06/2018 - 09/2006
5	Geographic Atrophy 03/2014 - 10/2008
4	Neoplasm Metastasis (Metastasis) 01/2018 - 01/2017
4	Retinal Diseases 03/2014 - 01/2006
4	Retinal Degeneration 06/2009 - 04/2002
3	Adenocarcinoma of Lung 01/2022 - 01/2016
3	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2019
3	Hepatocellular Carcinoma (Hepatoma) 03/2021 - 01/2018
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2021 - 11/2019
3	Atherosclerosis 01/2021 - 01/2018
3	Alzheimer Disease (Alzheimer's Disease) 10/2020 - 09/2006
3	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 01/2017
3	Carcinogenesis 01/2018 - 06/2014
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2018 - 01/2017
3	Pathologic Neovascularization 01/2016 - 11/2009
3	Aneuploidy (Aneuploid) 11/2015 - 01/2014
3	Diabetic Retinopathy (Retinopathy, Diabetic) 02/2015 - 08/2008
3	Vascular Diseases (Vascular Disease) 06/2012 - 04/2008
3	Familial Exudative Vitreoretinopathies 03/2011 - 03/2004
2	Diarrhea 06/2022 - 01/2022
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 01/2020
2	Heart Failure 01/2021 - 07/2016
2	Disease Progression 01/2021 - 08/2015
2	Stomach Neoplasms (Stomach Cancer) 10/2020 - 03/2020
2	Virus Diseases (Viral Diseases) 10/2020 - 01/2020
2	Pain (Aches) 12/2018 - 07/2014
2	Inborn Genetic Diseases (Disease, Hereditary) 06/2018 - 12/2016
2	Thrombosis (Thrombus) 06/2018 - 12/2016
2	Lymphoma (Lymphomas) 01/2018 - 01/2016
2	Epilepsy (Aura) 08/2017 - 08/2017
2	Macular Edema 01/2016 - 01/2006
2	Cicatrix (Scar) 01/2013 - 09/2007
2	Stargardt Disease 10/2010 - 03/2007

Drug/Important Bio-Agent (IBA)

29	Proteins (Proteins, Gene)FDA Link 06/2022 - 03/2004
22	Retinaldehyde (Retinal)IBA 01/2022 - 04/2002
9	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2016
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 04/2008
8	DNA (Deoxyribonucleic Acid)IBA 03/2019 - 06/2009
6	RNA (Ribonucleic Acid)IBA 01/2022 - 11/2015
6	Biological ProductsIBA 01/2018 - 10/2014
5	Pharmaceutical PreparationsIBA 09/2020 - 06/2011
4	CytokinesIBA 06/2022 - 11/2011
4	LipidsIBA 01/2022 - 10/2010
4	Transcription Factors (Transcription Factor)IBA 01/2022 - 04/2006
4	VaccinesIBA 12/2021 - 05/2017
4	Ranibizumab (Lucentis)FDA Link 01/2016 - 12/2007
4	Complement System Proteins (Complement)IBA 03/2014 - 02/2006
4	Retinal Pigments (Pigments, Visual)IBA 10/2010 - 10/2008
3	Interleukin-6 (Interleukin 6)IBA 06/2022 - 12/2016
3	InflammasomesIBA 05/2022 - 07/2014
3	Cell-Free Nucleic AcidsIBA 03/2021 - 11/2015
3	Crystallins (Crystallin)IBA 01/2021 - 07/2015
3	AntibodiesIBA 10/2020 - 02/2008
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 07/2012
3	Amino Acids FDA Link 06/2018 - 03/2002
3	Serine (L-Serine)FDA Link 01/2018 - 01/2004
3	Verteporfin (Visudyne)FDA Link 01/2015 - 12/2007
3	Fatty Acids (Saturated Fatty Acids)IBA 04/2014 - 06/2009
3	Complement Factor H (Factor H)IBA 08/2012 - 09/2006
3	PeripherinsIBA 01/2006 - 04/2002
2	CreatinineIBA 12/2022 - 08/2014
2	Tyrosine Kinase InhibitorsIBA 01/2022 - 09/2020
2	C-Reactive ProteinIBA 01/2022 - 10/2020
2	Blood Glucose (Blood Sugar)IBA 01/2021 - 11/2018
2	Peptides (Polypeptides)IBA 10/2020 - 02/2008
2	EnzymesIBA 10/2020 - 10/2010
2	Circulating Tumor DNAIBA 01/2020 - 11/2015
2	SugarsIBA 11/2018 - 01/2016
2	Creatine Kinase (Creatine Phosphokinase)IBA 01/2018 - 01/2017
2	Arginine (L-Arginine)FDA Link 01/2018 - 01/2004
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 08/2017 - 08/2017
2	Janus KinasesIBA 01/2017 - 11/2011
2	Tyrosine (L-Tyrosine)FDA Link 01/2017 - 10/2014
2	c-Mer Tyrosine KinaseIBA 03/2016 - 04/2012
2	LanosterolIBA 10/2015 - 07/2015
2	Angiogenesis InhibitorsIBA 02/2015 - 06/2012
2	Phenylalanine (L-Phenylalanine)FDA Link 10/2014 - 10/2008
2	Estrogens (Estrogen)FDA Link 01/2013 - 06/2009
2	Cysteine (L-Cysteine)FDA Link 03/2011 - 01/2004
2	Small Interfering RNA (siRNA)IBA 10/2008 - 04/2008
2	ZincIBA 02/2008 - 08/2007

Therapy/Procedure

26	Therapeutics 01/2022 - 10/2008
3	Intravitreal Injections 02/2015 - 01/2006
3	Transplantation 07/2014 - 01/2013
2	Intraocular Lenses (Intraocular Lens) 12/2019 - 03/2016
2	Acupuncture Points (Acupuncture Point) 12/2018 - 12/2016
2	Stents 06/2018 - 12/2016
2	Transcutaneous Electric Nerve Stimulation (TENS) 07/2015 - 07/2014
2	Lasers (Laser) 02/2013 - 01/2010